Making Strides Against Kidney Cancer
Join with the AACR to find better ways to prevent and treat kidney cancer.
Kidney cancer is among the most common cancers in the United States, with over 62,000 new diagnoses and over 14,000 deaths in 2016, according to
Also known as renal cancer,
kidney cancer is often treated with surgery to remove all or part of the affected organ. Some patients may be given chemotherapy or radiation therapy after surgery to destroy unseen cancer cells that may remain following the procedure. For a few patients, most commonly those with advanced disease, treatment may include a molecularly targeted therapeutic or an immunotherapeutic.
Smoking is a risk factor for kidney cancer, as is misuse of certain pain medicines, including over-the-counter drugs. In addition, certain genetic conditions, such as von Hippel-Lindau disease, increase a person’s risk of developing kidney cancer.
March is Kidney Cancer Awareness Month.
What Is the AACR Doing in This Area?
Since 2012, AACR has partnered with
Kure It to offer several kidney cancer-focused grants. Kure It has supported efforts in this area with more than $1 million in grants awarded in collaboration with the AACR.
In 2016, the AACR expanded this partnership to offer the Kure It-AACR Research Grant for Immunotherapy in Kidney Cancer. This grant represents a joint effort to promote and support innovative cancer research focusing on immunological aspects of, or treatments for, kidney cancer. The recipient of the 2016 grant was Anna Meseguer, PhD, for her study, "Could TIM-1 Constitute a New Target for Renal Carcinoma Immunotherapy?”.
The AACR's mission is to
prevent and cure all forms of cancer.